Azathioprine hepatotoxicity after liver transplantation

114Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

We report the first two cases of apparent azathioprine hepatotoxicity occurring after liver transplantation. The two patients exhibited jaundice, elevated serum transaminase activities and histopathological features of sinusoidal congestion and centrilobular hepatocellular degeneration 17 and 61 days after transplantation. After withdrawal of azathioprine, liver test results improved immediately in both patients. Recurrence of liver injury after another challenge with azathioprine was seen in the first case. Previously, fatal venoocclusive disease occurring after kidney transplantation had been attributed to azathioprine. Irreversible venoocclusive disease and the reversible hepatotoxicity described in this report (i.e., sinusoidal congestion with centrizonal necrosis) most likely represent different stages of hepatic endotheliitis caused by azathioprine. Thus early diagnosis of azathioprine hepatotoxicity is of great importance. (HEPATOLOGY 1991;14:806–810). Copyright © 1991 American Association for the Study of Liver Diseases

Cite

CITATION STYLE

APA

Sterneck, M., Wiesner, R., Ascher, N., Roberts, J., Ferrell, L., Ludwig, J., & Lake, J. (1991). Azathioprine hepatotoxicity after liver transplantation. Hepatology, 14(5), 806–810. https://doi.org/10.1002/hep.1840140511

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free